Lisanti Capital Growth, LLC Acadia Pharmaceuticals Inc Transaction History

Lisanti Capital Growth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$36.42 - $57.0 $2.96 Million - $4.64 Million	-81,398 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$39.26 - $52.73 $269,637 - $362,149	-6,868 Reduced 7.78%	81,398 $3.95 Million
Q1 2020 May 11, 2020	SELL	$31.65 - $46.87 $1.09 Million - $1.61 Million	-34,285 Reduced 27.98%	88,266 $3.73 Million
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $544,091 - $772,336	15,026 Added 13.97%	122,551 $5.24 Million
Q3 2019 Nov 06, 2019	BUY	$22.22 - $44.01 $1.46 Million - $2.89 Million	65,665 Added 156.87%	107,525 $3.87 Million
Q2 2019 Aug 05, 2019	SELL	$23.32 - $28.12 $1.51 Million - $1.82 Million	-64,675 Reduced 60.71%	41,860 $1.12 Million
Q1 2019 May 13, 2019	BUY	$16.17 - $27.38 $1.72 Million - $2.92 Million	106,535 New	106,535 $2.86 Million

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.45B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.